Given that microglia are the predominant resident immune cells in the brain and that SRGN expression peaked at 12–24 h after MCAO, by which time only a few peripherally immune cells would have infiltrated, we assumed that microglia were the main contributors to the increase of SRGN following stroke during the early stage. The gene discussed is SRGN; the disease is stroke disorder.